Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 2001 January; 84(1): 126–133.
Published online 2001 January 1. doi:  10.1054/bjoc.2000.1521
PMCID: PMC2363605

Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy


From 1940 through the 1960s, diethylstilbestrol (DES), a synthetic oestrogen, was given to pregnant women to prevent pregnancy complications and losses. Subsequent studies showed increased risks of reproductive tract abnormalities, particularly vaginal adenocarcinoma, in exposed daughters. An increased risk of breast cancer in the DES-exposed mothers was also found in some studies. In this report, we present further follow-up and a combined analysis of two cohorts of women who were exposed to DES during pregnancy. The purpose of our study was to evaluate maternal DES exposure in relation to risk of cancer, particularly tumours with a hormonal aetiology. DES exposure status was determined by a review of medical records of the Mothers Study cohort or clinical trial records of the Dieckmann Study. Poisson regression analyses were used to estimate relative risks (RR) and 95% confidence intervals (CI) for the relationship between DES and cancer occurrence. The study results demonstrated a modest association between DES exposure and breast cancer risk, RR = 1.27 (95% CI = 1.07–1.52). The increased risk was not exacerbated by a family history of breast cancer, or by use of oral contraceptives or hormone replacement therapy. We found no evidence that DES was associated with risk of ovarian, endometrial or other cancer. © 2001 Cancer Research Campaign

Keywords: DES, oestrogens, breast cancer, endometrial cancer, ovarian cancer, cancer

Full Text

The Full Text of this article is available as a PDF (85K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Antunes CM, Strolley PD, Rosenshein NB, Davies JL, Tonascia JA, Brown C, Burnett L, Rutledge A, Pokempner M, Garcia R. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med. 1979 Jan 4;300(1):9–13. [PubMed]
  • Beral V, Colwell L. Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers. Br Med J. 1980 Oct 25;281(6248):1098–1101. [PMC free article] [PubMed]
  • Bibbo M, Haenszel WM, Wied GL, Hubby M, Herbst AL. A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med. 1978 Apr 6;298(14):763–767. [PubMed]
  • Calle EE, Mervis CA, Thun MJ, Rodriguez C, Wingo PA, Heath CW., Jr Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol. 1996 Oct 1;144(7):645–652. [PubMed]
  • Clark LC, Portier KM. Diethylstilbestrol and the risk of cancer. N Engl J Med. 1979 Feb 1;300(5):263–264. [PubMed]
  • Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15;332(24):1589–1593. [PubMed]
  • Colton T, Greenberg ER, Noller K, Resseguie L, Van Bennekom C, Heeren T, Zhang Y. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA. 1993 Apr 28;269(16):2096–2100. [PubMed]
  • DIECKMANN WJ, DAVIS ME, RYNKIEWICZ LM, POTTINGER RE. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol. 1953 Nov;66(5):1062–1081. [PubMed]
  • Greenberg ER, Barnes AB, Resseguie L, Barrett JA, Burnside S, Lanza LL, Neff RK, Stevens M, Young RH, Colton T. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med. 1984 Nov 29;311(22):1393–1398. [PubMed]
  • Hadjimichael OC, Meigs JW, Falcier FW, Thompson WD, Flannery JT. Cancer risk among women exposed to exogenous estrogens during pregnancy. J Natl Cancer Inst. 1984 Oct;73(4):831–834. [PubMed]
  • Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 Apr 15;284(15):878–881. [PubMed]
  • Hoover R, Fraumeni JF, Everson R, Myers MH. Cancer of the uterine corpus after hormonal treatment for breast cancer. Lancet. 1976 Apr 24;1(7965):885–887. [PubMed]
  • Hoover R, Gray LA, Sr, Fraumeni JF., Jr Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer. Lancet. 1977 Sep 10;2(8037):533–534. [PubMed]
  • Noller KL, Fish CR. Diethylstilbestrol usage: Its interesting past, important present, and questionable future. Med Clin North Am. 1974 Jul;58(4):793–810. [PubMed]
  • Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000 Jan 26;283(4):485–491. [PubMed]
  • Vessey MP, Fairweather DV, Norman-Smith B, Buckley J. A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol. 1983 Nov;90(11):1007–1017. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK